文献速递眼底病与葡萄膜炎神经眼科

新生血管性年龄相关性黄斑变性患者的Charles Bonnet综合征:与质子泵抑制剂的关联

The Charles Bonnet Syndrome in Patients With Neovascular Age-Related Macular Degeneration: Association With Proton Pump Inhibitors.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

在葡萄牙单中心连续纳入510例新生血管性AMD患者筛查Charles Bonnet综合征(CBS),500例符合标准,CBS患病率为9.0%(45/500)。二元logistic回归显示高龄(P=0.002)、口服质子泵抑制剂(PPI)(P=0.022)和视力差(P=0.004)与CBS发生相关;PPI使CBS风险从7%(20/304)升至15%(25/167),比值比为2.154,且该风险增加独立于年龄(P=0.598)和视力(P=0.739)。

要点

  • 新生血管性AMD患者中CBS患病率为9.0%(45/500)。
  • PPI使CBS风险从7%(20/304)升至15%(25/167),比值比为2.154。
  • 高龄、PPI服用和视力差与CBS发生相关,PPI风险增加独立于年龄和视力。

核心结论

  • 新生血管性AMD患者中CBS患病率较高,主要影响高龄和视力差者;PPI似乎独立于视力损失程度增加幻觉发生风险。

研究设计与样本

  • 在葡萄牙单中心连续纳入510例新生血管性AMD患者进行CBS筛查,采用结构化问卷系统访谈精神健康个体,分为CBS组和非CBS组,比较人口学数据、当前用药和眼部风险因素;500例符合纳入标准,471例数据完整者纳入最终分析。

主要发现

  • CBS患病率为9.0%(45/500)。
  • 二元logistic回归显示高龄(P=0.002)、PPI摄入(P=0.022)、视力差(P=0.004)与CBS发生相关。
  • PPI使CBS风险从7%(20/304)升至15%(25/167),比值比为2.154。
  • PPI所致幻觉风险增加独立于年龄(P=0.598)和视力(P=0.739)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigate the prevalence of the Charles Bonnet syndrome (CBS) in patients with neovascular age-related macular degeneration (AMD) and analyze the role of oral proton pump inhibitors (PPIs) and other potential risk factors. METHODS: A total of 510 consecutive patients with neovascular-AMD followed at a single tertiary center in Portugal were screened for CBS. Using a structured questionnaire, psychiatrically healthy individuals were interviewed systematically and divided into a CBS group and a non-CBS group. Demographic data, current medication, and ocular risk factors were collected and compared between the two groups. RESULTS: A total of 500 patients met the inclusion criteria and 471 with complete data were included in the final analysis. The prevalence of CBS was 9.0% (45/500). Using a binary logistic regression model, correlations were found between older age (P = 0.002), PPI intake (P = 0.022), poor visual acuity (P = 0.004), and development of CBS. PPIs doubled the risk of CBS from 7% (20/304) to 15% (25/167), with an odds ratio of 2.154. The increased risk for visual hallucinations caused by PPIs was independent of age (P = 0.598) and visual acuity (P = 0.739). CONCLUSIONS: The prevalence of CBS in neovascular-AMD patients is high and mainly affects older individuals with poor visual acuity. PPIs seem to increase the risk of development of hallucinations independently of the degree of visual loss.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Leandro JE, Beato J, Pedrosa AC, et al. The Charles Bonnet Syndrome in Patients With Neovascular Age-Related Macular Degeneration: Association With Proton Pump Inhibitors. Invest Ophthalmol Vis Sci. 2017. PMID: 28829845. doi:10.1167/iovs.16-21270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。